NKARTA INC's ticker is NKTX and the CUSIP is 65487U108. A total of 84 filers reported holding NKARTA INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,522 | +5.6% | 19,800 | +66.4% | 0.00% | – |
| Q2 2023 | $26,061 | -93.6% | 11,900 | -89.7% | 0.00% | – |
| Q1 2023 | $410,267 | -69.3% | 115,568 | -48.2% | 0.00% | – |
| Q4 2022 | $1,336,674 | -69.4% | 223,151 | -32.7% | 0.00% | -100.0% |
| Q3 2022 | $4,363,000 | -27.2% | 331,542 | -31.9% | 0.00% | 0.0% |
| Q2 2022 | $5,994,000 | +94.9% | 486,548 | +80.0% | 0.00% | – |
| Q1 2022 | $3,076,000 | +21.9% | 270,275 | +64.4% | 0.00% | – |
| Q4 2021 | $2,523,000 | +217.0% | 164,399 | +474.6% | 0.00% | – |
| Q3 2021 | $796,000 | -54.4% | 28,610 | -48.0% | 0.00% | – |
| Q2 2021 | $1,744,000 | – | 55,019 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 2,034,703 | $31,233,000 | 6.06% |
| Novo Holdings A/S | 2,793,864 | $42,886,000 | 2.03% |
| RA Capital Management | 5,605,129 | $86,039,000 | 1.52% |
| Deep Track Capital, LP | 1,264,426 | $19,409,000 | 1.37% |
| NEA Management Company, LLC | 2,904,974 | $44,591,000 | 0.90% |
| Vivo Capital, LLC | 512,225 | $7,863,000 | 0.47% |
| Pinz Capital Management, LP | 40,000 | $614,000 | 0.24% |
| Rock Springs Capital Management LP | 507,248 | $7,786,000 | 0.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 40,200 | $617,000 | 0.14% |
| EMC Capital Management | 12,548 | $193,000 | 0.10% |